Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.

Guichard, S M; Else, R; Reid, E; Zeitlin, B; Aird, R; Muir, M; Dodds, M; Fiebig, H; Sadler, P J; Jodrell, D I

Guichard, S M; Else, R; Reid, E; Zeitlin, B; Aird, R; Muir, M; Dodds, M; Fiebig, H; Sadler, P J; Jodrell, D I.

Affiliation

Guichard SM; Pharmacology and Drug Development Group, Cancer Research UK Centre, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK.

Biochem Pharmacol ; 71(4): 408-15, 2006 Feb 14.

Article in En | MEDLINE | ID: mdl-16360645

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Ruthenium Compounds / Carcinoma, Non-Small-Cell Lung / Xenograft Model Antitumor Assays / Lung Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Biochem Pharmacol Year: 2006 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links